News

October 28, 2020

Dafinger C, Mandel AM, Braun A, Göbel H, Burgmaier K, Massella L, Mastrangelo A, Dötsch J, Benzing T, Weimbs T, Schermer B, Liebau MC. The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation. J Cell Mol Med. 2020 Oct 28. doi: 10.1111/jcmm.16014. Epub ahead of print. PMID: 33112055.

Related Links

August 21, 2020

Dr. Weimbs was awarded a research grant from the Department of Defense (Peer Reviewed Medical Research Program, Investigator-Initiated Research Award). The title of the study is "Ketosis as a therapy for polycystic kidney disease".

June 05, 2020

THE PKD FOUNDATION AWARDED A GRANT TO ROMAN-ULRICH MÜLLER, M.D. AND THOMAS WEIMBS, PH.D.

to conduct a clinical trial titled: "KETO-ADPKD — A pilot trial of ketogenic dietary interventions in ADPKD". This pilot and feasibility trial will be conducted at the University Hospital in Cologne, Germany.

November 13, 2019

Carney, E.F. Ketosis slows the progression of PKD. Nat Rev Nephrol (2019) doi:10.1038/s41581-019-0226-4

Related Links

October 20, 2019

Congratulations to all authors!

Related Links

Pages